Biophysical characterization of the interaction between hepatic glucokinase and its regulatory protein: impact of physiological and pharmacological effectors.
about
Pathway-selective insulin resistance and metabolic disease: the importance of nutrient fluxDynamic localization of glucokinase and its regulatory protein in hypothalamic tanycytesMolecular basis for the role of glucokinase regulatory protein as the allosteric switch for glucokinaseStructural Basis for Regulation of Human Glucokinase by Glucokinase Regulatory ProteinAntidiabetic effects of glucokinase regulatory protein small-molecule disruptorsAnalysis of the co-operative interaction between the allosterically regulated proteins GK and GKRP using tryptophan fluorescenceDiscovery of Small-Molecule Glucokinase Regulatory Protein Modulators That Restore Glucokinase Activity.Glucokinase regulatory protein: complexity at the crossroads of triglyceride and glucose metabolism.Acetylation of glucokinase regulatory protein decreases glucose metabolism by suppressing glucokinase activity.Glucokinase activators for diabetes therapy: May 2010 status reportMicroarray analysis of gene expression in liver, adipose tissue and skeletal muscle in response to chronic dietary administration of NDGA to high-fructose fed dyslipidemic ratsSmall-Molecule Allosteric Activation of Human Glucokinase in the Absence of Glucose.Mutational analysis of allosteric activation and inhibition of glucokinase.A patent review of glucokinase activators and disruptors of the glucokinase--glucokinase regulatory protein interaction: 2011-2014.Molecular targeting of the GK-GKRP pathway in diabetes.Influence of heparin mimetics on assembly of the FGF.FGFR4 signaling complex.Antidiabetic Disruptors of the Glucokinase-Glucokinase Regulatory Protein Complex Reorganize a Coulombic Interface.Characterization of RA839, a Noncovalent Small Molecule Binder to Keap1 and Selective Activator of Nrf2 Signaling.Evolution of vertebrate glucokinase regulatory protein from a bacterial N-acetylmuramate 6-phosphate etherase.
P2860
Q26820876-C3087888-D433-4B76-972A-C554B0218851Q27343153-6A8807BB-26B9-4D38-A16A-71FACBB639FBQ27678490-9556BCEC-44FF-45B7-9509-BD8B16B9039BQ27679719-11F7945A-123A-4022-A2C9-4D464F28B182Q27687521-CD09B6D3-CA8D-4C02-AC8C-22091CFE2B8AQ33945387-F88E2864-685A-45E0-ACA0-E51ADC627EEFQ35143696-4869A157-273A-48DD-AA7A-8B4C523895E6Q35578341-E41DFCE8-1E02-4D15-AC1F-AEDD3D42D786Q36333610-4858E167-144B-40EC-BBD6-A34DF2C15C45Q36783849-EF0086FF-66DF-4FEA-A7DF-913B321CE843Q37294679-D7CAD45A-390E-4D47-8EAD-DC9C26C50D3AQ37342791-1066CF24-C30A-4146-98F2-6664BCE243D8Q37733839-2A277F30-04C3-469F-8854-D0DDAC06BAB9Q38211348-1B996CF6-75BA-48FA-82EA-5CC2DF80232CQ38260964-597B74BF-2378-4667-A5A7-9BEA4A2DD065Q38343318-903F6D07-69E2-4C78-A190-1B2BAE714723Q38682504-08C1818F-23DC-4145-9F75-F677492B1ACEQ41914517-BE16D72B-B03A-4ECE-B029-24D7F507FB11Q43294057-B5A63BB5-F63C-4956-822A-78035CD11AF5
P2860
Biophysical characterization of the interaction between hepatic glucokinase and its regulatory protein: impact of physiological and pharmacological effectors.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Biophysical characterization o ...... and pharmacological effectors.
@ast
Biophysical characterization o ...... and pharmacological effectors.
@en
Biophysical characterization o ...... and pharmacological effectors.
@nl
type
label
Biophysical characterization o ...... and pharmacological effectors.
@ast
Biophysical characterization o ...... and pharmacological effectors.
@en
Biophysical characterization o ...... and pharmacological effectors.
@nl
prefLabel
Biophysical characterization o ...... and pharmacological effectors.
@ast
Biophysical characterization o ...... and pharmacological effectors.
@en
Biophysical characterization o ...... and pharmacological effectors.
@nl
P2093
P2860
P356
P1476
Biophysical characterization o ...... and pharmacological effectors.
@en
P2093
Andreas Batzer
Janina Boyken
Oliver Anderka
Oliver Boscheinen
Ursula Aschenbach
P2860
P304
31333-31340
P356
10.1074/JBC.M805434200
P407
P577
2008-09-22T00:00:00Z